Related Experiment Videos
[Principles of gene therapy in tumors]
1Odd. experimentální virologie, Ustav hematologie a krevní transfuze, Praha.
Abstract:
Gene therapy (GT) of cancer represents one of the most promising and exciting innovations in contemporary medicine. Several different strategies of GT of cancer have been developed. In spite of the rapid methodological progress their exploitation encounters a variety of problems. The most pertinent are associated with the use of vectors for gene transfer. Nowadays, virus-based vectors are preferred to the physical-chemical approaches. A special position in the methodology of cancer GT belongs to the so-called suicide genes. The expression of these genes in tumour cells results in their death provided they have been exposed to certain, originally innocuous substances. Combination of suicide genes with those coding for cytokines may eventually yield a very efficient means both for prevention and treatment of cancer. GT is connected with a number of considerable scientific, organizational and ethical problems. Coping with them requires extraordinary effort and well-organized and deliberate international cooperation.
Insights
Gene therapy (GT) offers a promising approach to cancer treatment, utilizing strategies like suicide genes and cytokine gene combinations. Overcoming challenges in gene transfer vectors and addressing ethical concerns are crucial for its advancement.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Context:
- Gene therapy (GT) is a rapidly advancing field with significant potential in cancer treatment.
- Current strategies face challenges, particularly concerning the efficiency and safety of gene transfer vectors.
- Virus-based vectors are currently favored over physical-chemical methods for gene delivery.
Purpose:
- To review the current landscape of gene therapy strategies for cancer treatment.
- To highlight the role and potential of suicide genes and cytokine-encoding genes in cancer GT.
- To identify the scientific, organizational, and ethical challenges impeding the clinical application of cancer GT.
Summary:
- Cancer gene therapy employs diverse strategies, with suicide gene therapy showing particular promise.
- The combination of suicide genes with cytokine genes presents a potent approach for cancer prevention and treatment.
- Effective gene transfer, primarily utilizing viral vectors, remains a critical hurdle.
Impact:
- Successful implementation of cancer GT could revolutionize oncological care.
- Addressing challenges requires significant scientific innovation and international collaboration.
- Ethical considerations must be carefully navigated for responsible advancement of the field.